PublicationsDiatech Admin2018-12-12T10:54:12+01:00

Publications

Leader in the development, production and
commercialisation of pharmacogenetics tests
for cancer precision medicine.

103, 2025

Veronica Agostinelli et al., The Impact and Performance of the Molecular Tumor Board: Three-Year Activity in Precision Medicine for Treatment of Patients with Cancer from the Marche Region, in Italy

1802, 2025

HAL?M ÖZÇEV?K ET AL., Genetic mutations and prognostic indicators in differentiated thyroid cancer: a molecular perspective

1502, 2025

Robrto Montalti et al., Prognostic role of postoperative persistence of ctDNA molecular signature after liver resection for colorectal liver metastases: Preliminary results from a prospective study

1302, 2025

Orhan Gorukmez et al., RNA-based next-generation sequencing approach to non-small cell lung cancer: A single center experience in Turkey

1302, 2025

Seda Er Özilhan et al., Correlation of PD-L1 and HIF-1 Alpha Expression with KRAS Mutation and Clinicopathological Parameters in Non-Small Cell Lung Cancer

2801, 2025

Fahmideh Bagrezaei et al., Assessment of the quality of life in metastatic colorectal cancer patients with KRAS gene mutant: a case-control study

2701, 2025

Elisabetta Maffei et al., Suitability of Different Cytological Preparations for Molecular Analysis of Advanced Non-Small Cell Lung Cancers

1601, 2025

Francesca Pagani et al., Concurrent RB1 and P53 pathway disruption predisposes to the development of a primitive neuronal component in high-grade gliomas depending on MYC-driven EBF3 transcription

801, 2025

Duhita Mirikar et al., Comparative analysis of EGFR mutations in circulating tumor DNA and primary tumor tissues from lung cancer patients using BEAMing PCR

201, 2025

Jessica Lucchetti et al., Aflibercept-Based and Bevacizumab-Based Second Line Regimens in Patients with Metastatic Colorectal Cancer: Propensity Score Weighted-Analysis from a Multicenter Cohort

2112, 2024

Carlotta Ceccon et al., MLH1 gene promoter methylation status partially overlaps with CpG methylator phenotype (CIMP) in colorectal adenocarcinoma

212, 2024

Federico Nichetti et al., Molecular characterization and clinical relevance of MGMT-silenced pancreatic cancer